Tagged with M

PHARMISA South Africa South Africa carries one of the world’s most disproportionate disease burdens, the worst of so-called westernised diseases, such as cardiac disease, diabetes etc on the one hand and the developmental infectious diseases, such as HIV, AIDS and TB on the other. South Africa represents 0.4% of the world’s population, yet…

Nycomed South Africa Mr Norman, could you tell us a few words on the transformation process that the company is currently going through? Takeda acquired Nycomed in October 2011, because it was an excellent strategic fit for both companies. It significantly strengthened Takeda’s geographic reach outside Japan and the United States, the company’s…

MSD South Africa If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa, you are in the top ten. What are your aspirations? Our Aspiration is to consistently out grow the Market. With more than 10 brands…

MC Pharma SA Could you introduce to our readers MC Pharma’s business model in the South African market as well as the main milestones in the company’s development over the recent years? MC Pharma is a licensed pharmaceutical company and acts as a Holder of the Certificate of Registration (Marketing Authorisation Holder; MAH),…

Abex Pharmaceutica Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations. Could you compare the two and tell us what position you enjoyed the most? I think I prefer the creative…

Dream CIS South Korea has a much shorter history of clinical trials than many other advanced economies. In your view, what is the potential for South Korea’s clinical trial industry today? The quality of Korean medical service is already top notch; it is truly world class. However, the environment here has been…

Histostem After spending a large part of your career as a university professor, what drove you to create your own company, Histostem, in 2000? In 1993, I actually established a bone marrow bank for the first time in Korea when I was a professor of the Catholic University in Seoul, Korea.…

Amayeza Abuntu (SA 2011) Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic French story. I met my wife in France 10 years ago during a medical product training session that we had…

Aspen The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and manufacturing infrastructure”. What was the original strategy behind getting the best from the Mexican market – specifically with the acquisition of the Latin America business from India-based Strides Arcolab…

Bomi de Mexico You took over BOMI as President and CEO only last year. Could you give us a brief background on BOMI Mexico and yourself? BOMI Mexico was founded in 1995. The mother company is Italian – and the Italian founder saw the potential in Latin America before most other pharmaceutical logistics…

Mexico Despite being in the Mexican market for over twenty years, biosimilars have never been regulated as a separate entity. They have always been regulated as simply another category of generic medicines.  “This enabled almost unmonitored competition from China, India, South Korea and other fast-growing countries, which sometimes caused more damage…

Merck Sharp & Dohme (MSD) Romania You have only just arrived from Korea to head the Romanian operations at MSD. Just recently, you told in an interview with Medica Academica that MSD Romania enjoys a good reputation within MSD worldwide. Can you first elaborate to our readers what factors underlie this strong reputation? When I was…